LOL, no excuses when LP dilutes in pennies post UK approval and share price hits new all time lows a few months post UK approval.
The more the minions BS things such as Flaskworks/Eden, tissue agnostic or label expansion outside GBM as the reason for the lengthy review process, it becomes clear that UK approval is going to be further delayed. And LP will have nothing meaningful post UK approval either. Endless dilution to continue for years!
No excuses for both you and Slave when August comes and goes without UK approval news.
Market Data 
Markets 
AI
